Noninfectious Complications of Blood Transfusion

  • Anne F. Eder
    From the Biomedical Headquarters, American Red Cross, Washington, DC (Dr Eder); and the Blood Bank of San Bernardino and Riverside Counties, San Bernardino, Calif (Dr Chambers). Dr Chambers is now with Riverside Methodist Hospital, Columbus, Ohio
  • Linda A. Chambers
    From the Biomedical Headquarters, American Red Cross, Washington, DC (Dr Eder); and the Blood Bank of San Bernardino and Riverside Counties, San Bernardino, Calif (Dr Chambers). Dr Chambers is now with Riverside Methodist Hospital, Columbus, Ohio

説明

<jats:title>Abstract</jats:title><jats:p>Context.—Serious noninfectious complications are far more likely to occur than viral disease transmission from blood component transfusion.</jats:p><jats:p>Objective.—To compile a comprehensive list of the noninfectious risks of transfusion, examples of published risk estimates, and summaries of recent information regarding cause, prevention, or management of noninfectious transfusion risks.</jats:p><jats:p>Data Sources.—Information was obtained from peer-reviewed English-language medical journal publications since 1990.</jats:p><jats:p>Conclusions.—Early complications, although potentially more serious, usually occur less frequently (&lt;1 in 1000 transfusions) than late complications, which often affect more than 1% of recipients. Areas of active investigation and discussion include acute hemolytic reactions, transfusion-related acute lung injury, red cell alloimmunization, platelet transfusion refractoriness, and transfusion immunosuppression. Continued effort toward research and education to promote recognition and prevention of noninfectious complications associated with blood components is warranted.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ